TOKYO & NEW YORK & DÜSSELDORF, Germany--(BUSINESS WIRE)--To contribute to reducing the risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals and nutritional supplements, Asahi ...
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals To contribute to reducing the risk of potentially carcinogenic nitrosamine impurities in ...
Asahi Kasei Offers Pharmaceutical Excipient Ceolus(TM) with Nitrite Concentration of 0.1 ppm or Less
To contribute to reducing the risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals and nutritional supplements, Asahi Kasei now offers Ceolus™ microcrystalline cellulose (MCC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback